Assembly Biosciences, Inc. (ASMB) Misses Q2 EPS by 4c

Assembly Biosciences, Inc. (NASDAQ: ASMB) reported Q2 EPS of ($0.32), $0.04 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Assembly Biosciences, Inc. (ASMB) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c